Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1

Interventions

pembrolizumab 553Specimen Handling 466Carboplatin 442Magnetic Resonance Spectroscopy 430Cyclophosphamide 415Cisplatin 397Radiotherapy 312Gemcitabine 309Bevacizumab 309Paclitaxel 295Biopsy 259Drug Therapy 249Capecitabine 242fludarabine 239Oxaliplatin 239Nivolumab 225venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 147durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Ketones × Clear all
NCT06155708 2025-01-22

Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome

McGill University

Phase NA Recruiting
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡